> Medidata > Worldwide Clinical Trials Selects Medidata to Streamline Clinical Global Site Reimbursements
 

Worldwide Clinical Trials Selects Medidata to Streamline Clinical Global Site Reimbursements

White Paper Published By: Medidata
Medidata
Published:  Nov 10, 2017
Type:  White Paper
Length:  2 pages

With clinical trial sites under increasing economic pressure, timely payments from sponsors are critical for keeping sites focused on patient enrollment. However, many sponsors and CROs face delays and avoidable headaches by manually processing complex payment requests and tracking reimbursement calculations with disparate systems. These activities are error-prone and labor intensive, and make it difficult to track study costs, split payments, or trigger payments based on study milestones – not to mention, they can lead to rising trial costs from site turnover given 40% of clinical trial investigators cite payments as their top concern.1 Worldwide Clinical Trials faced similar challenges with their payment process related to midstream changes, multiple site payees, and reporting requirements. Over an 18-month search, the company, “set out to rethink and innovate one of the major burdens sponsors have with all clinical trials: getting paid on time,” said Worldwide CFO Anthony Doyle.2



Tags :